Delusional Disorder
27
5
6
14
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.4%
2 terminated out of 27 trials
87.5%
+0.9% vs benchmark
19%
5 trials in Phase 3/4
7%
1 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 14 completed trials
Clinical Trials (27)
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis
Enhancing Veteran-Clinical Collaboration in VA PRRCs
SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities
Shared Decision Making for Antipsychotic Medications
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness
Young Adults With Violent Behavior During Early Psychosis (Aim 2)
Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders
The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care
Feasibility of a Novel Process-based Treatment for Patients With Psychosis
Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
Research Into Antipsychotic Discontinuation and Reduction Trial
Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders
Integrated Care in Psychotic Disorders With Severe Mental Illness
A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia
Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)